Cargando…
Allosteric cross-talk in chromatin can mediate drug-drug synergy
Exploitation of drug–drug synergism and allostery could yield superior therapies by capitalizing on the immensely diverse, but highly specific, potential associated with the biological macromolecular landscape. Here we describe a drug–drug synergy mediated by allosteric cross-talk in chromatin, wher...
Autores principales: | Adhireksan, Zenita, Palermo, Giulia, Riedel, Tina, Ma, Zhujun, Muhammad, Reyhan, Rothlisberger, Ursula, Dyson, Paul J., Davey, Curt A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379107/ https://www.ncbi.nlm.nih.gov/pubmed/28358030 http://dx.doi.org/10.1038/ncomms14860 |
Ejemplares similares
-
Nucleosome acidic patch-targeting binuclear ruthenium compounds induce aberrant chromatin condensation
por: Davey, Gabriela E., et al.
Publicado: (2017) -
Fighting Cancer with Transition Metal Complexes: From Naked DNA to Protein and Chromatin Targeting Strategies
por: Palermo, Giulia, et al.
Publicado: (2015) -
Engineering nucleosomes for generating diverse chromatin assemblies
por: Adhireksan, Zenita, et al.
Publicado: (2021) -
Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
por: Adhireksan, Zenita, et al.
Publicado: (2014) -
Near-atomic resolution structures of interdigitated nucleosome fibres
por: Adhireksan, Zenita, et al.
Publicado: (2020)